Literature DB >> 2453448

Monoclonal antibody to human cross-linked fibrin.

A Houranieh1, B E Statland, G L Davis, R K Ito, V Relias, B Kudryk, E J Yunis.   

Abstract

Cross-linked Fibrin II was prepared using Kabi grade (L) fibrinogen. Fibrin plasmic digest was separated on Sepharose CL-6B. Fragments Mr 135-300 kDa were used to immunize 6-9 weeks old female BALB-c mice. A stable hybridoma secreting monoclonal antibody (MAb) TD-1 (IgG 2a, Kappa) was prepared by fusion using myeloma cells (P3-NS1/1-Ag4-1) and immunized cells. Fibrinogen and plasmin digest of fibrinogen in serial dilutions did not compete with the immunizing antigen. To prove that TD-1 binds specifically to cross-linked fibrin, immunoprecipitation with S. aureus and affinity chromatography were performed. In both experiments, we demonstrated that TD-1 binds specifically to a protein Mr greater than 200 kDa which is found in XL-fibrin and not fibrinogen. Reduced samples showed the antibody bands (heavy and light chains) and three protein bands, Mr greater than 80 kDa (gamma-gamma dimer), Mr greater than 45 kDa (beta chain of fragment D) and Mr greater than 16 kDa (alpha chain from fragment D) were present. TD-1 reacted strongly with HPLC fraction of the immunizing antigen Mr 220 kDa (probably DD/E complex). Affinity binding constants (Scatchard Plot Analysis) were determined. The highest affinity was obtained with XL-fibrin fraction Mr 220 kDa, KD = 1.39 X 10(-8) and high molecular weight XL-fibrin fragments, KD = 1.6 X 10(-7). Fragment DD had KD of 2.8 X 10(-6). These results suggest that TD-1 is specific for the DD region of human cross-linked Fibrin II.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453448     DOI: 10.1089/hyb.1988.7.55

Source DB:  PubMed          Journal:  Hybridoma        ISSN: 0272-457X


  1 in total

1.  Detection of experimental thrombi in rabbits with an 131I-labelled fibrin-specific monoclonal antibody.

Authors:  K Z Walker; L J Milner; G J Bautovich; P Borham; A K Wood; D B Rylatt; P Martin; P G Bundesen; G R Boniface
Journal:  Eur J Nucl Med       Date:  1990
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.